EDIT-ART
KUZBASS CARDIOLOGY CENTRE IS 25 YEARS OLD
Purpose. To improve efficiency and safety of anticoagulant therapy in patients with prosthetic heart valves by developing and implementing original approaches: 1) sinus rhythm restoration after simultaneous mitral valve replacement with maze procedure, 2) pharmacogenetics approach for individual choice of anticoagulants, and 3) the implementation of patient education program.
Materials and methods. 525 patients with prosthetic heart valves were included in the study using cluster sampling in the period from 2008–2013. Group 1 (n=118) patients underwent the study aimed at assessing the restoration of sinus rhythm using original approaches, Group 2 (n=249) patients were included in the study aimed at assessing the efficiency of education program, and Group 3 (n=216) patients were included in the study aimed at assessing the efficiency of pharmacogenetics-based warfarin therapy. All patients underwent on-pump heart valve replacement. Genomic methods as well as non-invasive ultrasound monitoring of intracardiac hemodynamic parameters were used in the study.
Results. Simultaneous mitral valve replacement with maze procedure resulted in the restoration of sinus rhythm in 61,8 % of cases; scheduled cardioversion 1,5 months after cardiac surgery ensured sinus rhythm restoration in 84,8 % of patients, and radiofrequency catheter ablation in patients with biological prosthetic heart valves 6 months after cardiac surgery allowed both sinus rthym restoration and warfarin withdrawal. The introduction of pharmacogenetic approach to warfarin dosing in the early postoperative period resulted in a 2-fold reduction in the time of warfarin dose adjustment and a 25,2 % increase of the therapeutic range of anticoagulation level. The implementation of training program based on the continuity of inpatient and outpatient care allowed decreasing 1,8-fold the risk of thrombotic complications and 2,6-fold hemorrhagic complications 2 years after heart valve replacement. The introduction of the strategy aimed at the improvement of efficiency and safety of warfarin therapy demonstrated the benefits of biological heart valve replacement and the feasibility of an integrated approach.
Conclusion. The introduction of the integrated approach composed of the strategies for sinus rhythm restoration, information and motivational approach, and pharmacogenetic approach, ensures a reduction in hemorrhagic and thrombotic complications, improving quality control for warfarin therapy, awareness, and treatment adherence.
We prepared polycaprolactone (PCL) and polyhydroxybutyrate/valerate (PHBV)/polycaprolactone (PCL) 2 mm vascular grafts using electrospinning. The structure of the graft surface along with the physico-mechanical and viscoelastic properties were investigated by scanning electron microscopy, universal testing machine (n=20), and arterial pulsatile flow circuit (n=12), respectively. We also assessed hemocompatibility and thromboresistance of the inner graft surface (n=12). Cell adhesion and viability were investigated using EA.hy 926, an endothelial cell line that was cultured on the cultural plate, PCL, and PHBV/PCL scaffolds during 6 days.
PCL and PHBV/PCL grafts consisted of ≤ 4 μm diameter fibers which were randomly distributed and formed ≤ 40 μm diameter pores. The durability, elasticity, and stiffness of PCL grafts were 2,7-fold lower, 10,7-fold higher, and 2,9-fold higher, respectively, compared to autologous saphenous veins (р<0,001). However, the durability, elasticity, and stiffness of PHBV/PCL grafts were 1,9-fold higher, 1,8-fold lower, and 6,9-fold higher in comparison with PCL grafts (р<0,001). Viscoelastic properties of both PCL and PHBV/PCL grafts differed from native arteries (p<0,001) but were more similar to them then Dacron and ePTFE grafts. After the contact with blood, inner surface of PHBV/PCL grafts contained minimal amount of proteins and blood cells, and there were no signs of platelet activation. However, PCL grafts contained a high amount of proteins and induced platelet activation. After 6 days of culture, the number of EA.hy 926 cells was lower on PCL scaffolds compared to the PHBV/PCL scaffolds and cultural plate; the viability of the cells was similar.
Purpose. The purpose of this study was to create a model and interactive calculator for a differentiated choice of revascularization strategy in patients with ST-elevation myocardial infarction (STEMI) and coronary artery multivessel disease (MVD).
Material and methods. The study included 327 patients with STEMI and MVD undergoing primary percutaneous coronary intervention (PCI). Patients were divided into two groups: 1) Multivessel stenting (MS) (n=91); 2) Staged PCI (SP) (n=236). Study endpoints over 12 months were significant adverse cardiovascular events. Relative frequency of occurrence of an adverse outcome was evaluated and prognostic value for each of 12 demographic, clinical and angiographic factor was calculated for each revascularization strategy.
Results. The negative predictive value for adverse outcome in patients undergoing MS strategy had the following factors: myocardial infarction in past; severe coronary atherosclerosis (SYNTAX Score≥23); Age ≥65 years; female. Negative predictive value for SP strategy had the following factors: stroke in past; myocardial infarction in past; polyvascular atherosclerosis; three-vessel coronary artery disease; using of bare metal stents. The main result of this study was creation of interactive calculator for determine the optimal revascularization strategy for STEMI patients with MVD.
Conclusion. Using the developed model of differentiated choice of the optimal revascularization strategy and created calculator can improve treatment outcomes for STEMI patients with MVD.
EPIDEMIOLOGY OF DISEASES OF THE CIRCULATORY
Background. Currently, the influence of specific factors on mortality rates for circulatory system disease (CSD) is actively studied by numerous researches. Purpose. To study and compare medical care practitioners’ estimation of the factors affecting the mortality statistics for CSD in different regions of the Russian Federation.
Materials and Methods. Federal State Institution “National Research Centre for Preventive Medicine” compiled a questionnaire submitted to the Public Health Departments of the regions and researchers in preventive medicine and public health care from different regions of Russia. All the interviewees scored the influence of six factors as a leading cause of death (comorbid somatic pathology; comorbid psychopathology; comorbid alcohol and drug use disorders; non-compliance to treatment; ignorance of the major risk factors for CSD or refusal of their prevention; ignorance of the main manifestations (symptoms) of life-threatening diseases or complications) on mortality rates for CSD using a 1-to-5 rating scale. A total of 226 completed questionnaires were received: 37 questionnaires were completed by medical care practitioners from the Kemerovo region, 70 – from the Rostov region and 119 – from other regions of the Russian Federation. Three comparison groups were established.
Results. There were no statistically significant differences in the scores between the comparison groups of medical care practitioners. The average impact of comorbid somatic pathology according to the medical care practitioners’ estimation was 3,5; comorbid psychopathology – 2,7; comorbid alcohol and drug use disorders – 3,5; non-compliance to treatment – 4; ignorance of the major risk factors for CSD or refusal of their prevention – 3,8; ignorance of the main manifestations (symptoms) of life-threatening diseases or complications requiring first aid and emergency medical service – 3,9. Despite certain differences in the medical care practitioners’ estimation of the influence of selected factors on mortality rates for CSD (Kendall’s coefficient of concordance W=0,181) the degree of agreement was statistically significantly (p<0.0001) different from zero.
Conclusion. All these factors, estimated by the medical care practitioners, affect mortality rates for CSD. There were no statistically significant differences between the comparison groups’ estimates of the factors affecting mortality rates for CSD. There was a statistically significant low concordance between medical care practitioners in the use of the 1-to-5 rating scale.
The aim of this study was assessment of link between number of cardiovascular incidents among urban population and environmental conditions (concentration of air pollutants and the values of air temperature).
The analysis of the primary disease incidents, number of hospitalizations and deaths from cardiovascular diseases, as well as levels of air pollutants (mg/m3 ) and the air temperature (in °C) in Novokuznetsk, Kemerovo region for 2007–2012 was conducted. Cardiovascular disease data were adjusted for age (60 years and above 60 years). We analyzed the monthly average daily values of health and environment indicators. We used next statistical methods in our study: Mann-Whitney test, Kruskall-Wallis test and multiple regression analysis.
Indicators of morbidity, hospitalization, and mortality from cardiovascular disease in all age groups, except for hospitalization over the age of 60 years shows trends towards decline. Levels of air pollutants are characterized by multi-directional trend. Air pollutants that most frequently exceeded the maximum allowable concentration in Novokuznetsk in 2007–2012 were: Particulate Matter (6,7 % of samples), hydrogen fluoride (6,6 %), formaldehyde (3,8 %), phenol (2,5 %), carbon black (2,3 %), nitrogen dioxide (1,1 %). Regression analysis showed that rates of cardiovascular disease among Novokuznetsk population in 16–57 % of cases are explained by environmental conditions. The number of registered cases, hospitalizations and deaths from diseases of the cardiovascular system is connected directly with PM, hydrogen fluoride, formaldehyde levels and revesely with the air temperature. The contribution of PM and temperature to number of cardiovascular disease incidents is higher among elderly, compared with persons up to 60 years.
Thus, it is shown the combined influence of pollution levels and air temperature on the cardiovascular pathology of Novokuznetsk population.
INNOVATIONS IN EVALUATION OF COGNITIVE FUNCTIONS
ANALYTICAL REVIEWS OF LITERATURE
Purpose. Estimation the detection rate of pulmonary embolism (PE) and identifying risk factors for its development and adverse hospital events.
Materials and methods. 55 patients with PE were conducted the standard laboratory and instrumental examination.
Results. About half the patients were hospitalized in the first 24 hours from the time of development symptoms, while 23,6 % of patients had primary PE. The female person with obesity, hypertension, diabetes mellitus and coronary artery disease prevailed in the group of patients. The cancer pathology and thrombosis of deep vein occurred in 21,8 and 18,2 % respectively. The 41,9 % of patients underwent thrombolytic therapy, 52,7 % of patients – conservative treatment by anticoagulants, three patients underwent surgery thrombectomy from the pulmonary artery trunk. The death occurred in 12 (23,6 %) patients. Identified adverse prognostic factors: the low systolic blood pressure, dilatation of the right ventricle, the pulmonary artery trunk thrombosis and elevated levels of troponin-T. The elevated levels of D-dimer was observed in all patients with PE, regardless of the outcome. The frequency of PE was 1,03 % of the patients with pathology of the cardiovascular system have been admitted to the hospital during the year.
Conclusion. The presence of obesity and hypertension in patients with pulmonary embolism was detected most frequently. Adverse hospital events in patients with PE was significantly associated with arterial hypotension (p=0,0016), the presence of right ventricular dilatation (p=0,006), thrombosis of the pulmonary artery trunk (p=0,026) and increased troponin T levels (p=0,0426).
MATTERS OF EDUCATIONAL PROGRAMMES
INNOVATIONS IN ARRHYTHMOLOGY
CASE STUDY
Aim. Coronary artery bypass grafting (CABG) and tricuspid valve replacement (TVR) are available therapeutic options for cardiac allograft vasculopathy (CAV) and tricuspid regurgitation (TR), respectively after orthotopic heart transplantation (OHT). To our knowledge, these two procedures have never been reported simultaneously in a heart transplant recipient in the literature.
Materials and methods. We present the first incidence of a simultaneous CABG and TVR with a BiocorTMbioprosthetic valve in a heart transplant recipient 25 years after the original transplant operation, the longest reported duration before reoperation after OHT.
Results. Early postoperative course was complicated by complete heart block requiring placement of dual chamber pacemaker. Patient progressed well after this intervention and was eventually discharged to home and remained asymptomatic on follow-up.
Conclusion. Concomitatnt CAV and TVR for severe TR is a safe and effective treatment option with low perioperative mortality and favorable short and long term outcomes in heart transplant recipients.
Aim. Coronary artery bypass grafting (CABG) and tricuspid valve replacement (TVR) are available therapeutic options for cardiac allograft vasculopathy (CAV) and tricuspid regurgitation (TR), respectively after orthotopic heart transplantation (OHT). To our knowledge, these two procedures have never been reported simultaneously in a heart transplant recipient in the literature.
Materials and methods. We present the first incidence of a simultaneous CABG and TVR with a BiocorTMbioprosthetic valve in a heart transplant recipient 25 years after the original transplant operation, the longest reported duration before reoperation after OHT.
Results. Early postoperative course was complicated by complete heart block requiring placement of dual chamber pacemaker. Patient progressed well after this intervention and was eventually discharged to home and remained asymptomatic on follow-up.
Conclusion. Concomitatnt CAV and TVR for severe TR is a safe and effective treatment option with low perioperative mortality and favorable short and long term outcomes in heart transplant recipients.
ISSN 2587-9537 (Online)